Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
According to product SmPCs, nausea is very common (affecting more than 1 in 10 people), while vomiting and diarrhoea are common (affecting up to 1 in 10 people)
The approval was based on results from the phase 3 SURPASS program, which included active comparators of injectable semaglutide 1 mg, insulin glargine and insulin degludec
It also helps improve memory and overall focus
Mate A et al
US$ 24.26
US$ 25.42
US$ 29.36
US$ 21.65
